These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26873579)

  • 1. Mechanisms of vascularization in murine models of primary and metastatic tumor growth.
    Bugyik E; Renyi-Vamos F; Szabo V; Dezso K; Ecker N; Rokusz A; Nagy P; Dome B; Paku S
    Chin J Cancer; 2016 Feb; 35():19. PubMed ID: 26873579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications.
    Döme B; Hendrix MJ; Paku S; Tóvári J; Tímár J
    Am J Pathol; 2007 Jan; 170(1):1-15. PubMed ID: 17200177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the regulation of tumor dormancy by angiogenesis in experimental tumors.
    Indraccolo S
    Adv Exp Med Biol; 2013; 734():37-52. PubMed ID: 23143974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models.
    Bridgeman VL; Vermeulen PB; Foo S; Bilecz A; Daley F; Kostaras E; Nathan MR; Wan E; Frentzas S; Schweiger T; Hegedus B; Hoetzenecker K; Renyi-Vamos F; Kuczynski EA; Vasudev NS; Larkin J; Gore M; Dvorak HF; Paku S; Kerbel RS; Dome B; Reynolds AR
    J Pathol; 2017 Feb; 241(3):362-374. PubMed ID: 27859259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct contributions of angiogenesis and vascular co-option during the initiation of primary microtumors and micrometastases.
    Zhao C; Yang H; Shi H; Wang X; Chen X; Yuan Y; Lin S; Wei Y
    Carcinogenesis; 2011 Aug; 32(8):1143-50. PubMed ID: 21515914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intussusceptive microvascular growth in tumors.
    Ribatti D; Djonov V
    Cancer Lett; 2012 Mar; 316(2):126-31. PubMed ID: 22197620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.
    Giavazzi R; Sennino B; Coltrini D; Garofalo A; Dossi R; Ronca R; Tosatti MP; Presta M
    Am J Pathol; 2003 Jun; 162(6):1913-26. PubMed ID: 12759248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disproportion in Pericyte/Endothelial Cell Proliferation and Mechanisms of Intussusceptive Angiogenesis Participate in Bizarre Vessel Formation in Glioblastoma.
    Díaz-Flores L; Gutiérrez R; González-Gómez M; García MD; Díaz-Flores L; González-Marrero I; Ávila J; Martín-Vasallo P
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological features of vessel co-option versus sprouting angiogenesis.
    Latacz E; Caspani E; Barnhill R; Lugassy C; Verhoef C; Grünhagen D; Van Laere S; Fernández Moro C; Gerling M; Dirix M; Dirix LY; Vermeulen PB
    Angiogenesis; 2020 Feb; 23(1):43-54. PubMed ID: 31655928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview on the Different Patterns of Tumor Vascularization.
    Ribatti D; Pezzella F
    Cells; 2021 Mar; 10(3):. PubMed ID: 33805699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour vascularization: sprouting angiogenesis and beyond.
    Hillen F; Griffioen AW
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):489-502. PubMed ID: 17717633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.
    Vajkoczy P; Farhadi M; Gaumann A; Heidenreich R; Erber R; Wunder A; Tonn JC; Menger MD; Breier G
    J Clin Invest; 2002 Mar; 109(6):777-85. PubMed ID: 11901186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis in NSCLC: is vessel co-option the trunk that sustains the branches?
    Coelho AL; Gomes MP; Catarino RJ; Rolfo C; Lopes AM; Medeiros RM; Araújo AM
    Oncotarget; 2017 Jun; 8(24):39795-39804. PubMed ID: 26950275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early incorporated endothelial cells as origin of metastatic tumor vasculogenesis.
    Elzarrad K; Haroon A; Reed D; Al-Mehdi AB
    Clin Exp Metastasis; 2009; 26(6):589-98. PubMed ID: 19330530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genes and regulatory pathways involved in persistence of dormant micro-tumors.
    Almog N
    Adv Exp Med Biol; 2013; 734():3-17. PubMed ID: 23143972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rationale of antiangiogenic therapy].
    Tímár J; Paku S; Tóvári J; Döme B
    Magy Onkol; 2006; 50(2):141-51. PubMed ID: 16888678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current concepts of tumor-induced angiogenesis.
    Paku S
    Pathol Oncol Res; 1998; 4(1):62-75. PubMed ID: 9555124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization.
    Nolan DJ; Ciarrocchi A; Mellick AS; Jaggi JS; Bambino K; Gupta S; Heikamp E; McDevitt MR; Scheinberg DA; Benezra R; Mittal V
    Genes Dev; 2007 Jun; 21(12):1546-58. PubMed ID: 17575055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of angiogenesis, tumor growth, and metastasis by adenovirus-mediated gene transfer of human angiotensinogen.
    Bouquet C; Lamandé N; Brand M; Gasc JM; Jullienne B; Faure G; Griscelli F; Opolon P; Connault E; Perricaudet M; Corvol P
    Mol Ther; 2006 Aug; 14(2):175-82. PubMed ID: 16600689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cells expressing Bcl-2 promotes tumor metastasis by enhancing tumor angiogenesis, blood vessel leakiness and tumor invasion.
    Kumar P; Ning Y; Polverini PJ
    Lab Invest; 2008 Jul; 88(7):740-9. PubMed ID: 18490895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.